Percutaneous Nephrostomy Versus Retrograde Ureteral Stent for Management of Malignant Ureteral Obstruction in Adults: a Systematic Review of the Literature

BackgroundMalignant ureteral obstruction (MUO) is a common presentation in advanced urological and non-urological malignancies. Percutaneous nephrostomy (PCN) and retrograde ureteral stent (RUS) are the most commonly performed procedures to relieve the obstruction. The comparative effect...

Full description

Bibliographic Details
Main Authors: Walid Eshumani, Mathieu Roumiguié, Peter C. Black
Format: Article
Language:English
Published: The Société Internationale d’Urologie (SIU) 2023-09-01
Series:Société Internationale d’Urologie Journal
Subjects:
Online Access:https://siuj.org/index.php/siuj/article/view/301/253
_version_ 1827267799738744832
author Walid Eshumani
Mathieu Roumiguié
Peter C. Black
author_facet Walid Eshumani
Mathieu Roumiguié
Peter C. Black
author_sort Walid Eshumani
collection DOAJ
description BackgroundMalignant ureteral obstruction (MUO) is a common presentation in advanced urological and non-urological malignancies. Percutaneous nephrostomy (PCN) and retrograde ureteral stent (RUS) are the most commonly performed procedures to relieve the obstruction. The comparative effectiveness of PCN and RUS for decompression of MUO remains uncertain. PurposeTo systematically review the literature for evidence of improved efficacy of one of these procedures in terms of renal function preservation and clinical outcomes. MethodsWe searched Ovid Medline, Ovid EMBASE, CINAHL, Cochrane Central Register of Controlled Trials (CENTRAL), and Scopus from the date of inception to October 2022. In addition, gray literature was searched through OpenGray (https://opengrey.eu/), dissertation and thesis database (ProQuest) via (https://www.proquest.com), and Clinical trial.gov website. The reference lists of all the included studies were also searched.Two reviewers independently reviewed and selected studies, assessed the quality, and extracted the data. ResultsOverall, 25 eligible studies including 1864 patients compared PCN and RUS (head-to-head). PCN and RUS were found to be similarly effective in improving renal function. However, PCN appears to be superior in maintaining this reduction. The complication rate and quality of life were comparable between the 2 methods, but the length of hospital stay and the financial cost were significantly higher in the PCN group. The mean technical success rate in RUS was 70.3% (21% to 100%) and in PCN was 98.8% (90% to 100%). The conversion rate from RUS to PCN ranged from 10% to 42.6% (mean = 22.5%), while internalization of the PCN occurred in 11.7% to 98% of the patients (mean = 45.5%). ConclusionsBoth diversional methods are effective in management of MUO. However, because of the heterogeneity of the included studies, the superiority of one of the procedures cannot be concluded.
first_indexed 2024-03-08T18:31:42Z
format Article
id doaj.art-63ce3e4bd2534a0dbb1576e4c94186e5
institution Directory Open Access Journal
issn 2563-6499
language English
last_indexed 2025-03-22T04:39:29Z
publishDate 2023-09-01
publisher The Société Internationale d’Urologie (SIU)
record_format Article
series Société Internationale d’Urologie Journal
spelling doaj.art-63ce3e4bd2534a0dbb1576e4c94186e52024-04-27T23:31:21ZengThe Société Internationale d’Urologie (SIU)Société Internationale d’Urologie Journal2563-64992023-09-014540141410.48083/AYKF2124Percutaneous Nephrostomy Versus Retrograde Ureteral Stent for Management of Malignant Ureteral Obstruction in Adults: a Systematic Review of the LiteratureWalid EshumaniMathieu RoumiguiéPeter C. BlackBackgroundMalignant ureteral obstruction (MUO) is a common presentation in advanced urological and non-urological malignancies. Percutaneous nephrostomy (PCN) and retrograde ureteral stent (RUS) are the most commonly performed procedures to relieve the obstruction. The comparative effectiveness of PCN and RUS for decompression of MUO remains uncertain. PurposeTo systematically review the literature for evidence of improved efficacy of one of these procedures in terms of renal function preservation and clinical outcomes. MethodsWe searched Ovid Medline, Ovid EMBASE, CINAHL, Cochrane Central Register of Controlled Trials (CENTRAL), and Scopus from the date of inception to October 2022. In addition, gray literature was searched through OpenGray (https://opengrey.eu/), dissertation and thesis database (ProQuest) via (https://www.proquest.com), and Clinical trial.gov website. The reference lists of all the included studies were also searched.Two reviewers independently reviewed and selected studies, assessed the quality, and extracted the data. ResultsOverall, 25 eligible studies including 1864 patients compared PCN and RUS (head-to-head). PCN and RUS were found to be similarly effective in improving renal function. However, PCN appears to be superior in maintaining this reduction. The complication rate and quality of life were comparable between the 2 methods, but the length of hospital stay and the financial cost were significantly higher in the PCN group. The mean technical success rate in RUS was 70.3% (21% to 100%) and in PCN was 98.8% (90% to 100%). The conversion rate from RUS to PCN ranged from 10% to 42.6% (mean = 22.5%), while internalization of the PCN occurred in 11.7% to 98% of the patients (mean = 45.5%). ConclusionsBoth diversional methods are effective in management of MUO. However, because of the heterogeneity of the included studies, the superiority of one of the procedures cannot be concluded.https://siuj.org/index.php/siuj/article/view/301/253malignant ureteral obstructionhydronephrosispercutaneous nephrostomyretrograde ureteral sten
spellingShingle Walid Eshumani
Mathieu Roumiguié
Peter C. Black
Percutaneous Nephrostomy Versus Retrograde Ureteral Stent for Management of Malignant Ureteral Obstruction in Adults: a Systematic Review of the Literature
Société Internationale d’Urologie Journal
malignant ureteral obstruction
hydronephrosis
percutaneous nephrostomy
retrograde ureteral sten
title Percutaneous Nephrostomy Versus Retrograde Ureteral Stent for Management of Malignant Ureteral Obstruction in Adults: a Systematic Review of the Literature
title_full Percutaneous Nephrostomy Versus Retrograde Ureteral Stent for Management of Malignant Ureteral Obstruction in Adults: a Systematic Review of the Literature
title_fullStr Percutaneous Nephrostomy Versus Retrograde Ureteral Stent for Management of Malignant Ureteral Obstruction in Adults: a Systematic Review of the Literature
title_full_unstemmed Percutaneous Nephrostomy Versus Retrograde Ureteral Stent for Management of Malignant Ureteral Obstruction in Adults: a Systematic Review of the Literature
title_short Percutaneous Nephrostomy Versus Retrograde Ureteral Stent for Management of Malignant Ureteral Obstruction in Adults: a Systematic Review of the Literature
title_sort percutaneous nephrostomy versus retrograde ureteral stent for management of malignant ureteral obstruction in adults a systematic review of the literature
topic malignant ureteral obstruction
hydronephrosis
percutaneous nephrostomy
retrograde ureteral sten
url https://siuj.org/index.php/siuj/article/view/301/253
work_keys_str_mv AT walideshumani percutaneousnephrostomyversusretrogradeureteralstentformanagementofmalignantureteralobstructioninadultsasystematicreviewoftheliterature
AT mathieuroumiguie percutaneousnephrostomyversusretrogradeureteralstentformanagementofmalignantureteralobstructioninadultsasystematicreviewoftheliterature
AT petercblack percutaneousnephrostomyversusretrogradeureteralstentformanagementofmalignantureteralobstructioninadultsasystematicreviewoftheliterature